6 citations · 8 across the 3 of their papers we have counts for
3 papers
Quantifying efficiency gains of innovative designs of two-arm vaccine trials for COVID-19 using an epidemic simulation model
Rob Johnson, Chris Jackson, Anne Presanis +2
Clinical trials of a vaccine during an epidemic face particular challenges, such as the pressure to identify an effective vaccine quickly to control the epidemic, and the effect th…
Trends in risks of severe events and lengths of stay for COVID-19 hospitalisations in England over the pre-vaccination era: results from the Public Health England SARI-Watch surveillance scheme
Peter D. Kirwan, Suzanne Elgohari, Christopher H. Jackson +4
Background: Trends in hospitalised case-fatality risk (HFR), risk of intensive care unit (ICU) admission and lengths of stay for patients hospitalised for COVID-19 in England over…
Implications for HIV elimination by 2030 of recent trends in undiagnosed infection in England: an evidence synthesis
Anne M Presanis, Peter Kirwan, Ada Miltz +9
A target to eliminate Human Immuno-deficiency Virus (HIV) transmission in England by 2030 was set in early 2019. Estimates of recent trends in HIV prevalence, particularly the numb…